IRIS
PICCHIO, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.372
NA - Nord America 6.664
AS - Asia 5.922
SA - Sud America 1.678
AF - Africa 144
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 8
Totale 21.812
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.459
RU - Federazione Russa 3.798
SG - Singapore 2.213
CN - Cina 1.763
BR - Brasile 1.337
SE - Svezia 834
HK - Hong Kong 780
IT - Italia 657
VN - Vietnam 611
RO - Romania 536
ES - Italia 345
FR - Francia 329
DE - Germania 251
GB - Regno Unito 162
FI - Finlandia 146
AR - Argentina 141
IN - India 111
CA - Canada 104
MX - Messico 78
PL - Polonia 73
BD - Bangladesh 68
ID - Indonesia 61
EC - Ecuador 59
NL - Olanda 57
ZA - Sudafrica 57
TR - Turchia 50
IE - Irlanda 49
IQ - Iraq 44
AT - Austria 41
JP - Giappone 40
CO - Colombia 35
PY - Paraguay 28
CL - Cile 22
PE - Perù 22
AU - Australia 21
UA - Ucraina 20
SA - Arabia Saudita 18
MA - Marocco 17
PK - Pakistan 17
UZ - Uzbekistan 16
VE - Venezuela 16
NP - Nepal 15
JO - Giordania 14
DZ - Algeria 13
IR - Iran 13
KE - Kenya 13
PH - Filippine 12
EG - Egitto 11
LT - Lituania 11
MY - Malesia 11
AZ - Azerbaigian 10
BE - Belgio 10
IL - Israele 10
TN - Tunisia 10
UY - Uruguay 10
PT - Portogallo 9
BO - Bolivia 7
CZ - Repubblica Ceca 7
AE - Emirati Arabi Uniti 6
EU - Europa 6
KZ - Kazakistan 6
RS - Serbia 6
AL - Albania 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
MD - Moldavia 5
OM - Oman 5
CI - Costa d'Avorio 4
GR - Grecia 4
LB - Libano 4
PS - Palestinian Territory 4
SN - Senegal 4
TW - Taiwan 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
CH - Svizzera 3
HU - Ungheria 3
JM - Giamaica 3
KR - Corea 3
LV - Lettonia 3
PA - Panama 3
SC - Seychelles 3
TT - Trinidad e Tobago 3
AO - Angola 2
CR - Costa Rica 2
CY - Cipro 2
NZ - Nuova Zelanda 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
BH - Bahrain 1
BW - Botswana 1
BZ - Belize 1
CG - Congo 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
KG - Kirghizistan 1
KH - Cambogia 1
Totale 21.799
Salva come PNG Salva come JPEG
Città #
Dallas 3.103
Singapore 940
Moscow 801
Hong Kong 765
Ashburn 627
San Jose 489
Shanghai 371
Valencia 303
Hefei 299
Milan 271
Beijing 252
Lauterbourg 251
Lawrence 244
Princeton 244
New York 209
Ho Chi Minh City 202
Hanoi 146
São Paulo 115
Los Angeles 106
Munich 100
Orem 76
Helsinki 73
Boardman 70
Turku 59
Santa Clara 50
Warsaw 49
Dublin 48
Brooklyn 44
Rio de Janeiro 39
Montreal 35
Rome 35
Chennai 34
Tokyo 34
Frankfurt am Main 33
Da Nang 32
Johannesburg 31
Chicago 29
Denver 29
Stockholm 29
Washington 28
Poplar 27
Seattle 27
Belo Horizonte 26
London 26
Manchester 26
Atlanta 25
Haiphong 25
The Dalles 25
Nuremberg 24
Toronto 23
Amsterdam 22
Guangzhou 22
Quito 22
West Jordan 22
Ankara 21
Curitiba 21
Mexico City 21
Brasília 20
Phoenix 20
Dhaka 19
Houston 18
Council Bluffs 17
Lima 17
Shenzhen 17
Baghdad 16
Vienna 16
Barnet 15
Columbus 15
Guayaquil 15
Ninh Bình 15
Tashkent 15
Buenos Aires 14
Can Tho 14
Guarulhos 14
Manaus 14
New Delhi 14
Asunción 13
Boston 13
Buffalo 13
Campinas 13
Porto Alegre 13
Amman 12
Charlotte 12
Goiânia 12
Jakarta 12
Lappeenranta 12
Mumbai 12
Philadelphia 12
Bexley 11
Biên Hòa 11
Cape Town 11
Falkenstein 11
Fortaleza 11
Hangzhou 11
Naples 11
Ribeirão Preto 11
Salvador 11
Santiago 11
São Bernardo do Campo 11
Baku 10
Totale 11.685
Salva come PNG Salva come JPEG
Nome #
(11)C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms 1.421
11C-choline PET/CT and PSA kinetics 1.395
18F-FDG PET/MRI in endometrial cancer: systematic review and meta-analysis 179
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 178
68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours 172
18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease 169
11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy 161
11C-choline PET/CT predicts survival in prostate cancer patients with PSA < 1 NG/ml 161
A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors 157
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 155
[C-11]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy 154
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 151
[ 11C] Choline PET/CT Predicts Prostate Cancer-Specific Survival in Patients with Biochemical Failure During Androgen Deprivation Therapy 144
18F-FAZA PET/CT in pretreatment assessment of hypoxic status in high-grade glioma: correlation with hypoxia immunohistochemical biomarkers 139
11C-choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients 138
68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks 138
11C-CHOLINE-POSITRON EMISSION TOMOGRAPHY/ COMPUTERISED TOMOGRAPHY FOR PREOPERATIVE LYMPH- NODE STAGING IN INTERMEDIATE-RISK AND HIGH-RISK PROSTATE CANCER: COMPARISON WITH CLINICAL STAGING NOMOGRAMS 137
18F-FDG uptake by prosthetic arterial grafts in large vessel vasculitis is not specific for active disease: results from a cohort study 132
[11C]CHOLINE PET/CT for Early Detection of Tumor in Prostate Cancer Patients with PSA Level Lower Than 1.5 NG/ML 127
External validation of a convolutional neural network for the automatic segmentation of intraprostatic tumor lesions on 68Ga-PSMA PET images 126
null 126
18F-FAZA PET/CT in the Preoperative Evaluation of NSCLC: Comparison with 18F-FDG and Immunohistochemistry 126
[C-11] Choline Positron Emission Tomography/Computerized Tomography for Early Detection of Prostate Cancer Recurrence in Patients with Low Increasing Prostate Specific Antigen 125
Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance 125
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography 124
18F-FDG PET/CT and urothelial carcinoma: Impact on management and prognosis—a multicenter retrospective study 124
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors 121
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 120
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 120
Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort 120
A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM) 119
18F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu’s arteritis 118
18F-FAZA PET imaging in tumor hypoxia: A focus on high-grade glioma 118
18F-FAZA PET/CT Hypoxia Imaging of High-Grade Glioma Before and After Radiotherapy 117
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 116
Decoding the Heterogeneity of Malignant Gliomas by PET and MRI for Spatial Habitat Analysis of Hypoxia, Perfusion, and Diffusion Imaging: A Preliminary Study 116
18F-FDG PET/CT AND UROTHELIAL CARCINOMA: IMPACT ON MANAGEMENT AND PROGNOSIS—A MULTICENTER RETROSPECTIVE STUDY IN BOOK ROLE OF MEDICAL IMAGING IN CANCERS 116
11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients 115
Hypoxia pathway: 18F-FAZA 114
[11C]choline PET/CT for the detection of tumor recurrence in prostate cancer patients with PSA<1.5 ng/mL 114
Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy 113
11C-or18F-Choline PET/CT for imaging evaluation of biochemical recurrence of prostate cancer 113
[¹⁸F]fluorodeoxyglucose positron emission tomography/computed tomography and trophoblastic disease: the gynecologist perspective 112
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours 111
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 110
[11C]CHOLINE PET/CT FOR RESTAGING PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY AND NO EVIDENCE OF DISEASE ON CONVENTIONAL IMAGING 110
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters 107
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 106
PSMA PET in brain metastases: navigating diagnostic challenges– a thorough exploration 105
Effectiveness and safety of infliximab dose escalation in patients with refractory Takayasu arteritis: A real-life experience from a monocentric cohort 105
State of the art of radiomic analysis in the clinical management of prostate cancer: A systematic review 104
[C-11]choline-PET-guided helical tomotherapy and estramustine in a patient with pelvic-recurrent prostate cancer: local control and toxicity profile after 24 months 103
18F-FDG PET/CT in gastric MALT lymphoma: a bicentric experience 102
Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy 101
Systematic Review and Metanalysis on the Role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging for Intraprostatic Tumour Assessment 101
Advanced ovarian carcinoma: usefulness of [(18)F]FDG-PET in combination with CT for lesion detection after primary treatment 101
[F-18]fluorodeoxyglucose positron emission tomography as a useful indicator of metastatic gestational trophoblastic tumor: preliminary results in three patients 101
18F-FDG positron emission tomography compared with computed tomography in diagnosing recurrent ovarian carcinoma 98
Radiomics and artificial intelligence 97
Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness 96
Hypoxia PET imaging beyond 18F-FMISO in patients with high-grade glioma: 18F-FAZA and other hypoxia radiotracers 96
When to Perform Bone Scan in Patients with Newly Diagnosed Prostate Cancer: External Validation of the Currently Available Guidelines and Proposal of a Novel Risk Stratification Tool 95
18Fluorodeoxyglucose Positron Emission Tomography (18FDG-PET)-Guided Target Delineation in Lung Cancer 94
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study 94
PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature 91
CRITICAL ASSESSMENT OF THE PERFORMANCE OF PSA KINETICS FOR THE PREDICTION OF [11C]CHOLINE PET/CT IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY 90
18F-FDG PET/CT AND UROTHELIAL CARCINOMA: IMPACT ON MANAGEMENT AND PROGNOSIS—A MULTICENTER RETROSPECTIVE STUDY 88
The Role of Choline Positron Emission Tomography/Computed Tomography in the Management of Patients with Prostate-Specific Antigen Progression After Radical Treatment of Prostate Cancer 87
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis 87
Synergic role of preoperative 18F-fluorodeoxyglucose PET and MRI parameters in predicting histopathological features of endometrial cancer 85
The Challenge of External Generalisability: Insights from the Bicentric Validation of a [68Ga]Ga-PSMA-11 PET Based Radiomics Signature for Primary Prostate Cancer Characterisation Using Histopathology as Reference 84
Choline PET/CT features to predict survival outcome in high risk prostate cancer restaging: a preliminary machine-learning radiomics study 84
Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: An endearing tool for preoperative risk assessment 84
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography 82
Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers 78
[C-11]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy 78
FDG Uptake by Prosthetic Arterial Grafts in Large Vessel Vasculitis Is Not Specific for Active Disease 78
3D Spatial resolution proprieties of Molecubes β-Cube: Characterization with different isotopes 77
Concomitant Lung Cancer and Gastrointestinal Stromal Tumor: First Report of Hypoxia Imaging With 18F-FAZA PET/CT 76
18F-FDG PET/CT for Early Postradiotherapy Assessment in Solitary Bone Plasmacytomas 74
Imaging in evaluation of response to neo-adjuvant treatment 74
Combined Use of TBNA and EBUS-TBNA in the Preoperative Staging of Lung Cancer Patients 73
Increased Choline Uptake in Bronchioalveolar Cell Carcinoma with Negative FDG Uptake. A PET/CT and Pathology Study 73
18FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY (18FDG-PET)-GUIDED TARGET DELINEATION IN LUNG 72
Diagnosis of local recurrence after radical prostatectomy 72
Predictive value of 18F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study 72
Hypoxia and Amino Acid Imaging of High-Grade Glioma18F-FAZA PET/CT and 11C-Methionine PET/MRI 72
The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake 70
VALIDAZIONE TRAMITE LINFOADENECTOMIA PELVICA E RETROPERITONEALE DELLA ACCURATEZZA DELLA TC/PET CON 11CCOLINA NELLA DIAGNOSI DI METASTASI LINFONODALI IN PAZIENTI CON RECIDIVA BIOCHIMICA DI CARCINOMA PROSTATICO DOPO PROSTATECTOMIA RADICALE 67
Radiation treatment of lymph node recurrence from prostate cancer: Is 11C-choline PET/CT predictive of survival outcomes? 67
The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial 67
Dual tracer 68ga-dotatoc and 18f-fdg pet improve preoperative evaluation of aggressiveness in resectable pancreatic neuroendocrine neoplasms 67
Nuclear medicine in prostate cancer management 66
Detection and compensation of organ/lesion motion using 4D-PET/CT respiratory gated acquisition techniques 66
First evaluation of PET-based human bioDistribution and dosimetry of 18F-FAZA, a tracer for imaging tumor hypoxia 66
Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study 66
[18F]FDG-PET and [11C]Choline-PET uptake in different types of NSCLC: Comparison with histological and molecular data. 65
Combined 68Ga-DOTA-peptides and 18F-FDG PET in the diagnostic work-up of neuroendocrine neoplasms (NEN) 64
Fluorodeoxyglucose positron emission tomography improves preoperative staging of resectable lung metastasis 64
PET/MRI and prostate cancer 63
Totale 13.092
Salva come PNG Salva come JPEG
Categoria #
all - tutte 119.524
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.524
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 1 0 1
2021/2022222 1 11 1 96 14 7 13 12 18 29 5 15
2022/20231.532 543 314 123 36 23 178 81 124 43 31 5 31
2023/20241.006 52 45 149 102 66 168 36 104 12 60 54 158
2024/20254.332 529 66 65 99 141 302 1.162 285 584 441 288 370
2025/202614.905 927 1.466 3.291 1.935 924 351 1.169 889 3.388 565 0 0
Totale 22.271